// App-Quantinova.ai

OC 02.2 : Cooperation between PF4-specific antibodies in heparin-induced thrombocytopenia: a new mechanism potentially contributing to hypercoagulability and thrombosis

Researchers

Presenter

  • S. Billy

Principal Investigators

  • C. Vayne

  • N. Charuel

  • C. Pouplard

  • Y. Gruel

  • J. Rollin

Medical Centers

  • Université de Tours, TOURS, Centre, France

  • University Hospital of Tours, Tours, France

  • Université de Tours, Tours, Centre, France

  • University Hospital of Tours, Tours, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved